Phase I CD22 CAR T-cell trial updates

被引：3

作者：

Shah, Nirali N. ^{[1
]}

Shalabi, Haneen ^{[1
]}

Yates, Bonnie ^{[1
]}

Yuan, Constance ^{[1
]}

Qin, Haiying ^{[1
]}

Ombrello, Amanda ^{[2
]}

Wang, Hao-Wei ^{[1
]}

Hoffman, Leah ^{[1
]}

Minh Tran ^{[3
]}

Panch, Sandhya ^{[3
]}

Stetler-Stevenson, Maryalice ^{[1
]}

Jin, Jianjian ^{[1
]}

Mackall, Crystal ^{[4
]}

Highfill, Steve ^{[3
]}

Stroncek, David ^{[3
]}

Fry, Terry J. ^{[5
]}

机构：

[1] NCI, Bethesda, MD 20892 USA

[2] NHGRI, Bethesda, MD 20892 USA

[3] NIH, Bldg 10, Bethesda, MD 20892 USA

[4] Stanford, Palo Alto, CA USA

[5] Univ Colorado, Childrens Hosp Colorado, Denver, CO 80202 USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.SABCS18-LB-146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-146

引用

页数：4

共 50 条

[41] A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC).
Papa, Sophie
Adami, Antonella
Metoudi, Michael
Achkova, Daniela
van Schalkwyk, May
Pereira, Ana Parente
Bosshard-Carter, Leticia
Whilding, Lynsey
van der Stegen, Sjoukie
Davies, David
Farzaneh, Farzin
Urbano, Teresa Guerrero
Jeannon, Jean-Pierre
Spicer, James F.
Maher, John
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[42] UCART22: allogenic adoptive immunotherapy of leukemia by targeting CD22 with CAR T-cells
Gouble, Agnes
Schiffer-Mannioui, Cecile
Thomas, Severine
Gautron, Anne-Sophie
Poirot, Laurent
Smith, Julianne
CANCER RESEARCH, 2017, 77
[43] UCART22: An Allogenic Adoptive Immunotherapy of Leukemia by Targeting CD22 with CAR T-Cells
Gautron, Anne-Sophie
Schiffer-Mannioui, Cecile
Marechal, Alan
Thomas, Severine
Gouble, Agnes
Poirot, Laurent
Smith, Julianne
MOLECULAR THERAPY, 2017, 25 (05) : 54 - 55
[44] CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-. Cytokine Signature
Srinagesh, Hrishikesh
Baird, John H.
Agarwal, Neha
Su, Yi-Jiun
Kramer, Anne Marijn
Reschke, Agnes
Jeyakumar, Nikeshan
Bharadwaj, Sushma
Schultz, Liora Michal
Ramakrishna, Sneha
Davis, Kara L.
Sahaf, Bita
Feldman, Steven
Mackall, Crystal L.
Miklos, David B.
Muffly, Lori S.
Frank, Matthew J.
BLOOD, 2023, 142
[45] B cell signaling pathways in CD22, ST6Gal I and CD22/ST6Gal I null mice
Collins, BE
Bengtson, P
Nitschke, L
Marth, JD
Paulson, JC
GLYCOBIOLOGY, 2004, 14 (11) : 1140 - 1140
[46] Characterization of HLH-like manifestations as a CRS variant in CD22 CAR T cells
Lichtenstein, Daniel A.
Schischlik, Fiorella
Shao, Lipei
Steinberg, Seth M.
Yates, Bonnie
Wang, Hao-Wei
Wang, Yanyu
Inglefield, Jon
Dulau-Florea, Alina
Ceppi, Francesco
Hermida, Leandro C.
Stringaris, Kate
Dunham, Kim
Homan, Philip
Jailwala, Parthav
Mirazee, Justin
Robinson, Welles
Chisholm, Karen M.
Yuan, Constance
Stetler-Stevenson, Maryalice
Ombrello, Amanda K.
Jin, Jianjian
Fry, Terry J.
Taylor, Naomi
Highfill, Steven L.
Jin, Ping
Gardner, Rebecca A.
Shalabi, Haneen
Ruppin, Eytan
Stroncek, David F.
Shah, Nirali N.
BLOOD, 2021, 138 (24) : 2469 - 2484
[47] Modulation of CD22 Antigen Density Improves Efficacy of CD22 Chimeric Antigen Receptor (CAR) T Cells Against CD22lo B-Lineage Leukemia and Lymphoma
Ramakrishna, Sneha
Nguyen, Sang M.
Qin, Haiying
Highfill, Steven L.
Kraft, Ira
Shern, John
Walsh, Zachary
Dimitrov, Dimiter
Fry, Terry J.
BLOOD, 2017, 130
[48] CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
Tingdang Liu
Ximing Dai
Yien Xu
Tian Guan
Liangli Hong
Tahir Zaib
Qi Zhou
Ke Cheng
Xiaoling Zhou
Changchun Ma
Pingnan Sun
Journal of Translational Medicine, 21
[49] CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
Liu, Tingdang
Dai, Ximing
Xu, Yien
Guan, Tian
Hong, Liangli
Zaib, Tahir
Zhou, Qi
Cheng, Ke
Zhou, Xiaoling
Ma, Changchun
Sun, Pingnan
JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
[50] Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact
Collins, BE
Blixt, O
DeSieno, AR
Bovin, N
Marth, JD
Paulson, JC
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) : 6104 - 6109

← 1 2 3 4 5 →